Senate · Roll call 103 · Session 2 · 119th Congress · April 23, 2026
Recorded vote
Wyden Amdt. No. 5336; To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
48 Yea · 50 Nay · 2 Not votingFailed
D 46–0 · R 2–50
Every member · 100 recorded